Navigation Links
Nutraceutical Reports Fiscal 2009 Q2 Results
Date:4/30/2009

l impairment charge resulted in a net loss of $(20.2) million, or $(1.86) per diluted share, for the six months ended March 31, 2009, compared to net income of $7.6 million, or $0.67 per diluted share, for the same period of fiscal 2008. Excluding the above non-cash impairment charge, net income for the six months ended March 31, 2009 would have been $7.0 million, or $0.64 per diluted share.

Operating cash flow for the six months ended March 31, 2009 was $11.8 million compared to $9.4 million for the same period of fiscal 2008. This operating cash flow was used to invest $6.4 million in purchases of property and equipment and repay $5.5 million in net borrowings on the Company's revolving credit facility.

Bill Gay, chairman and chief executive officer, commented, "The economic environment continued to present challenges during the second quarter of fiscal 2009. During both the first and second quarters of fiscal 2009, net sales to many of our domestic and international customers were adversely affected by the decline in world economies. Despite these difficult circumstances, operating cash flow and Adjusted EBITDA remained strong. Gross profit margins remained strong at 53.5% for the second quarter and we were able to reduce inventories by $2.4 million. Additionally, synergies were achieved through reductions in operational and transitional costs related to businesses acquired over the last two years as well as year-over-year cost improvements in many of our selling, general and administrative areas."

Mr. Gay continued, "The uncertainties of the current environment will continue to present ongoing challenges as we strive to serve our customers and grow our business. Our management group is focusing on expanding revenues through customer promotions and product innovation, material sourcing improvements and further reducing controllable costs. Our long term business strategy of selling primarily to the H
'/>"/>

SOURCE Nutraceutical International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Physician Develops Resveratrol Evidence-Based Nutraceutical for Heart Health
2. Nutraceutical Reports Fiscal 2009 Q1 Results
3. Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
4. Nutraceutical Reports 2008 Fiscal Year End Results
5. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
6. Nutraceutical to Present at Canaccord Adams Healthy Living Conference
7. Nutraceuticals could prevent diabetes
8. Nutraceutical Reports Q3 Results
9. Dermatologists In Denial: Controversial New Chocolate Nutraceutical Claims to be Good for Your Skin
10. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
11. Berkeley Premium Nutraceuticals Pushes Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... York, NY (PRWEB) July 24, 2014 For the ... touring across the United States. The Scottish singer first became a ... Britain’s Got Talent. Her first song on the show was “I ... history. She has released five studio albums since her time on ... enough to perform in front of her American fans. The tour ...
(Date:7/24/2014)... The report, “Feed Palatability Enhancers & Modifiers Market by ... Pets, Aquaculture, and Others) - Global Trends & Forecasts ... & modifiers market with an analysis and projection of ... of feed flavors, sweeteners, and text rants. , Browse ... 275 pages and in-depth TOC on "Feed Palatability Enhancers ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 The North American ... the omega 3 & structured lipids market in North America ... America is estimated to grow from around $762.4 million in ... 6.6% from 2013 to 2018. , Browse through the TOC ... report, to get an idea of the in-depth analysis provided. ...
(Date:7/24/2014)... percent of all prenatal ultrasounds uncover antenatal hydronephrosis, ... abnormality in the United States. Many children with ... for the first few years of life with ... tract infections. Until recently, however, little evidence existed ... involves considerable cost and inconvenience for families. But ...
(Date:7/24/2014)... Skin Cancer cells work together to spread further and ... Reports. The discovery could lead to new drugs to ... , Cancer Research UK scientists at The University of ... growing, but not very good at invading the surrounding ... highly invasive but slow-growing. , In a tumour, ...
Breaking Medicine News(10 mins):Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 2Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 3Health News:Susan Boyle Tickets: Dazzling Deals Tickets Cuts Ticket Prices for Susan Boyle's 2014 North America Concert Tour 4Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 2Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 4Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 4Health News:North America Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $1,117 million in 2018 - New Report by MicroMarket Monitor 5Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:Piggy-backing cells hold clue to skin cancer growth 2
... , , , , , , ... Medical,International Limited (NYSE: MR ), a leading developer, ... at its annual general meeting of shareholders held in Hong ... the meeting, Mindray Medical International,s shareholders approved the,re-election of directors ...
... causes more pain than vodka, study finds , FRIDAY, Dec. ... a common indulgence -- and nasty hangovers a common consequence. ... lighter-colored beverages, they might feel a little better the next ... contain more toxic properties that provoke more painful hangovers than ...
... , , , NEWPORT BEACH, Calif., Dec. 18 ... announced today that it has given notice that it is ... Cumulative Convertible Preferred Stock ("Series B Preferred Stock") (NHP-PB - ... price per share of $103.875 plus an amount equal to ...
... thoughts may help explain interpersonal problems , FRIDAY, Dec. ... are less active than expected when they,re engaged in ... difficulties, say British researchers. , Using functional MRI, they ... whom had autism, while they were asked questions about ...
... CentraCare president is new chair , ST. PAUL, Minn., Dec. ... systems, recently elected or re-elected the following members to its board for ... Chair - Terence Pladson, M.D., president, CentraCare Health System, ... CEO, Queen of Peace Hospital, New Prague, Secretary/treasurer - ...
... , , HOUSTON, Dec. 18 ... largest provider of deathcare products and services in North America, ... has extended the expiry time of its offer (the "Offer") ... and outstanding common shares in the capital of Keystone North ...
Cached Medicine News:Health News:Mindray Medical International Limited Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 2Health News:For a Lighter Hangover, Avoid Darker Drinks 2Health News:For a Lighter Hangover, Avoid Darker Drinks 3Health News:For a Lighter Hangover, Avoid Darker Drinks 4Health News:Nationwide Health Properties, Inc. Announces the Redemption of All Outstanding Shares of 7.75% Series B Cumulative Convertible Preferred Stock 2Health News:Brain Imaging Sheds Light on Social Woes Related to Autism 2Health News:Minnesota Hospital Association Elects, Re-Elects Members to Board 2Health News:Service Corporation International Extends Offer for Keystone North America Inc. 2Health News:Service Corporation International Extends Offer for Keystone North America Inc. 3
(Date:7/24/2014)... 24, 2014  Kinex Pharmaceuticals announced the receipt of ... KX2-391 Ointment for the commencement of a Phase I ... third IND to be allowed by the US FDA ... a synthetic, orally active and highly selective inhibitor of ... the induction of p53, G2/M arrest of proliferating cell ...
(Date:7/24/2014)... -- Talyst, a market leader in pharmacy automation, will ... Veterans Homes (NASVH) Summer Conference in Charleston, ... is to ensure that each and every eligible US ... and respect which they have earned by their service ... Dispensing System, Talyst can help State Veterans Homes increase ...
(Date:7/24/2014)... , July 24, 2014  The American ... is supporting its mission to help address audit ... and exclusive agreement to be the information technology ... As the leading provider of billing and business ... unmatched HME industry expertise to support this important ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2
... Imaging announced today that it has received FDA 510(k) ... Analyzer® System to assess coronary branch vessels in addition ... artery disease (CAD). The clearance is the third for ... tool that automatically detects significant (50 percent and over) ...
... Medical, Inc., a private sports medicine device company specializing ... immediately, David B. Springer will succeed James Hart as ... Executive Chairman due to health reasons. Hart, ... CEO since the company,s inception in 2005, will continue ...
Cached Medicine Technology:Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 2Cayenne Medical, Inc. Appoints David B. Springer President & CEO 3
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Fenestrated 14 mm blades and canthus bar. Adjustable blade locking screws on outside of branches. Dull finish....
Double bent ends prevent wire from catching when pushed forward. Designed for use with the Castroviejo Snare (E3675). Package of 12 stainless steel wires. Overall length 4.3 inches....
Replacement snares for the E3525. 3 per package....
Medicine Products: